Cencora EBIT Margin 2010-2025 | COR

Cencora ebit margin for the quarter ending March 31, 2025 was 0.82%.

  • Cencora average ebit margin for 2024 was 0.81%, a 10% increase from 2023.
  • Cencora average ebit margin for 2023 was 0.9%, a 13.46% decline from 2022.
  • Cencora average ebit margin for 2022 was 1.04%, a 289.09% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Cencora EBIT Margin 2010-2025 | COR

  • Cencora average ebit margin for 2024 was 0.81%, a 10% increase from 2023.
  • Cencora average ebit margin for 2023 was 0.9%, a 13.46% decline from 2022.
  • Cencora average ebit margin for 2022 was 1.04%, a 289.09% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$135.9B
CVS Health (CVS)$77.3B
Elevance Health (ELV)$63.4B
DiDi Global (DIDIY)$26.5B
Labcorp Holdings (LH)$21.1B
Natera (NTRA)$19.1B
BioMerieux (BMXMF)$16B
EUROFINS SCIENT (ERFSF)$14.4B
Medpace Holdings (MEDP)$13.7B
CochLear (CHEOY)$13.1B
ICON (ICLR)$13B
Solventum (SOLV)$12.6B
Revvity (RVTY)$11.3B
Viatris (VTRS)$10.8B
Sonic Healthcare (SKHHY)$9B
Avantor (AVTR)$8.9B
HealthEquity (HQY)$8.4B
Charles River Laboratories (CRL)$8B
Caris Life Sciences,�Inc (CAI)$7.7B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5.1B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.2B
Surgery Partners (SGRY)$2.8B
Organon (OGN)$2.6B
Concentras Parent (CON)$2.5B
Alignment Healthcare (ALHC)$2.4B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B
GoodRx Holdings (GDRX)$1.8B